Cancer chemotherapy and pharmacology, Vol. 89, Issue 3, Pages 393-400, 2022

PMID: 35157101

Pediatric acute lymphoblastic leukemia (pALL) patients have better overall survival and methotrexate (MTX) is an effective drug used in their treatment. However, the treatment-related adverse effects (TRAEs) have a bigger impact on the therapy. In this study, we have evaluated the association of polymorphisms in genes encoding proteins engaged in MTX metabolism, and the cytogenetic aberrations with TRAEs.

Read More

  https://pubmed.ncbi.nlm.nih.gov/35157101/